Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Affan Denk, Kutbettin Demirdag, Ahmet Kalkan, Mehmet Ozden, Burhan Cetinkaya & Suleyman S. Kilic. (2015) In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey. Infectious Diseases 47:6, pages 364-369.
Read now
Read now
M. Sayan, Z. Yumuk, D. Dündar, O. Bilenoğlu, S. Erdenliğ, E. Yaşvar & A. Willke. (2008) Rifampicin Resistance Phenotyping of Brucella melitensis by rpoB Gene Analysis in Clinical Isolates. Journal of Chemotherapy 20:4, pages 431-435.
Read now
Read now
S. Kilic, M. Dizbay & H. Cabadak. (2008)
In Vitro Activity of Tigecycline, Tetracycline and Fluoroquinolones against Brucella melitensis
. Journal of Chemotherapy 20:1, pages 33-37.
Read now
Read now
Georgios Pappas, Nikolaos Akritidis & Leonidas Christou. (2007) Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Review of Anti-infective Therapy 5:6, pages 983-990.
Read now
Read now
Murat Dizbay, Selcuk Kilic, Kenan Hizel & Dilek Arman. (2007) Tigecycline: Its potential for treatment of brucellosis. Scandinavian Journal of Infectious Diseases 39:5, pages 432-434.
Read now
Read now
Articles from other publishers (36)
Masoumeh BeigSafoura MoradkasaniForough GoodarziMohammad Sholeh. (2024)
Prevalence of
Brucella melitensis
and
Brucella abortus
Fluoroquinolones Resistant Isolates: A Systematic Review and Meta-Analysis
. Vector-Borne and Zoonotic Diseases 24:1, pages 1-9.
Crossref
Crossref
Armin Rezaei Shahrabi, Safoura Moradkasani, Forough Goodarzi, Masoumeh Beig & Mohammad Sholeh. (2023) Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: A systematic review and meta-analysis. Microbial Pathogenesis 183, pages 106321.
Crossref
Crossref
Gamal Wareth, Maryam Dadar, Haytham Ali, Mahmoud E. R. Hamdy, Ahmad M. Al‐Talhy, Ahmed R. Elkharsawi, Ashraf A. Abd El Tawab & Heinrich Neubauer. (2022) The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management. Transboundary and Emerging Diseases 69:5.
Crossref
Crossref
Joost Boeckmans, Koen Magerman, Steven Vanvolsem, Reinoud Cartuyvels, Luc Waumans & Peter Messiaen. (2022)
Antibiotic and Surgical Treatment of a Ventriculoperitoneal Shunt-Related Soft Tissue Abscess Caused by
Brucella melitensis
. Annals of Internal Medicine: Clinical Cases 1:4.
Crossref
Crossref
Esra Gültekin, Muhammet Hamidullah Uyanık, Ayşe Albayrak & Selçuk Kılıç. (2021) Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey. European Journal of Medical Research 26:1.
Crossref
Crossref
Selçuk Kılıç, Bekir Çelebi & Meral Turan. (2021) Brucella melitensis and Brucella abortus genotyping via real-time PCR targeting 21 variable genome loci. Journal of Microbiological Methods 180, pages 106125.
Crossref
Crossref
Tuba Dal, Soner Sertan Kara, Aytekin Cikman, Cigdem Eda Balkan, Ziya Cibali Acıkgoz, Hasan Zeybek, Hakan Uslu & Rıza Durmaz. (2019) Comparison of multiplex real-time polymerase chain reaction with serological tests and culture for diagnosing human brucellosis. Journal of Infection and Public Health 12:3, pages 337-342.
Crossref
Crossref
Daniah F. Fatani, Walaa A. Alsanoosi, Mazen A. Badawi & Abrar K. Thabit. (2019) Ceftriaxone use in brucellosis: A case series. IDCases 18, pages e00633.
Crossref
Crossref
Felipe Francisco Tuon, Natacha Cerchiari, Juliana Clélia Cequinel, Elizabeth El Hajjar Droppa, Suzana Dal Ri Moreira, Tânia Portella Costa, Amanda de Paula Boni Navarro, Antonieta Milleo Handar & Margely Nunes de Souza. (2017) Guidelines for the management of human brucellosis in the State of Paraná, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 50:4, pages 458-464.
Crossref
Crossref
Mahzad Erami, Mansooreh Momen-Heravi, Reza Razzaghi & Saeed Alamian. (2016)
The Prevalence of
Brucella
Biotypes Isolated From Sterile Body Fluids of Patients With Brucellosis in Kashan, Iran in 2013
. Avicenna Journal of Clinical Microbiology and Infection 3:3, pages 33516-33516.
Crossref
Crossref
Pei Xiao, Hongxia Yang, Dongdong Di, Dongri Piao, Qiuxiang Zhang, Ruie Hao, Suxia Yao, Rong Zhao, Fanfei Zhang, Guozhong Tian, Hongyan Zhao, Weixing Fan, Buyun Cui & Hai Jiang. (2015) Genotyping of Human Brucella melitensis Biovar 3 Isolated from Shanxi Province in China by MLVA16 and HOOF. PLOS ONE 10:1, pages e0115932.
Crossref
Crossref
Rohaidah Hashim, Norazah Ahmad, Jama’ayah Mohamed Zahidi, B. Y. Tay, Azura Mohd Noor, Sakina Zainal, Hazwani Hamzah, S. H. Hamzah, T. S. Chow, P. S. Wong & K. N. Leong. (2014)
Identification and In Vitro Antimicrobial Susceptibility of
Brucella
Species Isolated from Human Brucellosis
. International Journal of Microbiology 2014, pages 1-5.
Crossref
Crossref
Zeki Yumuk & David O’Callaghan. (2012) Brucellosis in Turkey — an overview. International Journal of Infectious Diseases 16:4, pages e228-e235.
Crossref
Crossref
Hakan Erdem, Ayşegül Ulu-Kilic, Selim Kilic, Mustafa Karahocagil, Ghaydaa Shehata, Necla Eren-Tulek, Funda Yetkin, Mustafa Kemal Celen, Nurgul Ceran, Hanefi Cem Gul, Gurkan Mert, Suda Tekin-Koruk, Murat Dizbay, Ayse Seza Inal, Saygın Nayman-Alpat, Mile Bosilkovski, Dilara Inan, Nese Saltoglu, Laila Abdel-Baky, Maria Teresa Adeva-Bartolome, Bahadır Ceylan, Suzan Sacar, Vedat Turhan, Emel Yılmaz, Nazif Elaldi, Zeliha Kocak-Tufan, Kenan Uğurlu, Başak Dokuzoğuz, Hava Yılmaz, Sibel Gundes, Rahmet Guner, Nail Ozgunes, Asim Ulcay, Serhat Unal, Saim Dayan, Levent Gorenek, Ahmet Karakas, Yesim Tasova, Gaye Usluer, Yasar Bayindir, Behice Kurtaran, Oguz Resat Sipahi & Hakan Leblebicioglu. (2012) Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul Study. Antimicrobial Agents and Chemotherapy 56:3, pages 1523-1528.
Crossref
Crossref
Mohamed Abdel-Maksoud, Brent House, Momtaz Wasfy, Bassem Abdel-Rahman, Guillermo Pimentel, Gehan Roushdy & Erica Dueger. (2012) In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Annals of Clinical Microbiology and Antimicrobials 11:1, pages 24.
Crossref
Crossref
Murat Sayan, Selcuk Kılıc & Muhammet Hamidullah Uyanık. (2012) Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. Journal of Infection and Chemotherapy 18:1, pages 41-46.
Crossref
Crossref
Ali Fedakar, Canturk Cakalagaoglu, Oguz Konukoglu, Mehmet Yanartaş, Sinan Göçer, Rahmi Zeybek & Mehmet Balkanay. (2011) Treatment protocol and relapses of brucella endocarditis; cotrimoxazole in combination with the treatment of brucella endocarditis. Tropical Doctor 41:4, pages 227-229.
Crossref
Crossref
Selçuk Kılıç, Ivan N. Ivanov, Rıza Durmaz, Mehmet Refik Bayraktar, Ergin Ayaşlıoğlu, M. Hamidullah Uyanık, Hikmet Alışkan, Ekrem Yaşar, Gülçin Bayramoğlu, Ahmet Arslantürk, Gilles Vergnaud & Todor V. Kantardjiev. (2011) Multiple-Locus Variable-Number Tandem-Repeat Analysis Genotyping of Human Brucella Isolates from Turkey. Journal of Clinical Microbiology 49:9, pages 3276-3283.
Crossref
Crossref
Hai Jiang, Ling-ling Mao, Hong-yan Zhao, Lan-yu Li, Dong-ri Piao, Wen-qing Yao & Bu-yun Cui. (2010) MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. Transactions of the Royal Society of Tropical Medicine and Hygiene 104:12, pages 796-800.
Crossref
Crossref
Allen E. Jensen & Shirley M. Halling. (2010) Effect of polymyxin B and environmental conditions on isolation of Brucella species and the vaccine strain RB51. Comparative Immunology, Microbiology and Infectious Diseases 33:2, pages 121-131.
Crossref
Crossref
Hale Turan, Kivanc Serefhanoglu, Elif Karadeli, Funda Timurkaynak & Hande Arslan. (2009) A case of brucellosis with abscess of the iliacus muscle, olecranon bursitis, and sacroiliitis. International Journal of Infectious Diseases 13:6, pages e485-e487.
Crossref
Crossref
Helen S. Atkins, Stephen Spencer, Simon D. Brew, Dominic C. Jenner, Paul Russell, Alastair P. MacMillan, Stephen M. Eley & Andrew J.H. Simpson. (2009) Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection. International Journal of Antimicrobial Agents 34:5, pages 474-476.
Crossref
Crossref
Neşe DemirtürkTuna DemirdalNurettin Erben, Serap Demir, Zerrin Asci TurkanPasali Kilit & Elif Doyuk Kartal. (2008) Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment. Tropical Doctor 38:1, pages 59-62.
Crossref
Crossref
Cinzia Marianelli, Caterina Graziani, Carmela Santangelo, Maria Teresa Xibilia, Alida Imbriani, Rosa Amato, Domenico Neri, Mario Cuccia, Sebastiano Rinnone, Vincenzo Di Marco & Franco Ciuchini. (2007)
Molecular Epidemiological and Antibiotic Susceptibility Characterization of
Brucella
Isolates from Humans in Sicily, Italy
. Journal of Clinical Microbiology 45:9, pages 2923-2928.
Crossref
Crossref
Zafer Koc, Tuba Turunc & Can Boga. (2007) Gonadal brucellar abscess: Imaging and clinical findings in 3 cases and review of the literature. Journal of Clinical Ultrasound 35:7, pages 395-400.
Crossref
Crossref
Hale Turan, Hande Arslan, Özlem Kurt Azap, Kıvanç Şerefhanoğlu & Hikmet Uncu. (2007) In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.. International Journal of Antimicrobial Agents 30:2, pages 186-187.
Crossref
Crossref
BG Mantur, SK Amarnath & RS Shinde. (2007) REVIEW OF CLINICAL AND LABORATORY FEATURES OF HUMAN BRUCELLOSIS. Indian Journal of Medical Microbiology 25:3, pages 188-202.
Crossref
Crossref
Esragül Akıncı, Hürrem Bodur, Mustafa Aydın Çevik, Ayşe Erbay, Selim Sırrı Eren, İpek Zıraman, Neriman Balaban, Ali Atan & Gülüşan Ergül. (2006) A complication of brucellosis: Epididymoorchitis. International Journal of Infectious Diseases 10:2, pages 171-177.
Crossref
Crossref
Brian J. Barnes, Christopher Gerst, Jennifer R. Smith, Andrea R. Terrell & Michael E. Mullins. (2012) Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:1, pages 23-33.
Crossref
Crossref
Aun Turkmani, Alexandros Ioannidis, Athanasia Christidou, Anna Psaroulaki, Feidias Loukaides & Yiannis Tselentis. (2006) In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Annals of Clinical Microbiology and Antimicrobials 5:1.
Crossref
Crossref
Matthew E. Falagas & Ioannis A. Bliziotis. (2006) Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical Studies. Antimicrobial Agents and Chemotherapy 50:1, pages 22-33.
Crossref
Crossref
Fred C. Tenover. 2005. Frontiers in Antimicrobial Resistance. Frontiers in Antimicrobial Resistance
414
421
.
Şükran Köse, Selçuk Kiliç & Yusuf Özbel. (2005)
Identification of
Brucella
species isolated from proven brucellosis patients in Izmir, Turkey
. Journal of Basic Microbiology 45:4, pages 323-327.
Crossref
Crossref
Georgios Pappas, Nikolaos Akritidis, Mile Bosilkovski & Epameinondas Tsianos. (2005) Brucellosis. New England Journal of Medicine 352:22, pages 2325-2336.
Crossref
Crossref
Jay E. Gee, Barun K. De, Paul N. Levett, Anne M. Whitney, Ryan T. Novak & Tanja Popovic. (2004)
Use of 16S rRNA Gene Sequencing for Rapid Confirmatory Identification of
Brucella
Isolates
. Journal of Clinical Microbiology 42:8, pages 3649-3654.
Crossref
Crossref
Antonio Rivero-Román, José Luis Zambrana & Jerónimo Pachón-Díaz. (2004) ¿Tratamiento empírico de la fiebre de duración intermedia con doxiciclina?. Enfermedades Infecciosas y Microbiología Clínica 22:6, pages 365-366.
Crossref
Crossref